nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—Dimetacrine—Tamoxifen—pancreatic cancer	0.182	0.571	CrCrCtD
Oxcarbazepine—Promazine—Tamoxifen—pancreatic cancer	0.136	0.429	CrCrCtD
Oxcarbazepine—ALB—Erlotinib—pancreatic cancer	0.0534	0.116	CbGbCtD
Oxcarbazepine—CYP3A5—Tamoxifen—pancreatic cancer	0.0504	0.11	CbGbCtD
Oxcarbazepine—ALB—Irinotecan—pancreatic cancer	0.0482	0.105	CbGbCtD
Oxcarbazepine—ALB—Fluorouracil—pancreatic cancer	0.0463	0.101	CbGbCtD
Oxcarbazepine—CYP3A5—Erlotinib—pancreatic cancer	0.0429	0.0934	CbGbCtD
Oxcarbazepine—CYP2C19—Tamoxifen—pancreatic cancer	0.0407	0.0886	CbGbCtD
Oxcarbazepine—CYP3A5—Irinotecan—pancreatic cancer	0.0387	0.0844	CbGbCtD
Oxcarbazepine—CYP3A5—Docetaxel—pancreatic cancer	0.0284	0.0618	CbGbCtD
Oxcarbazepine—CYP3A5—Sunitinib—pancreatic cancer	0.0283	0.0616	CbGbCtD
Oxcarbazepine—CYP3A4—Tamoxifen—pancreatic cancer	0.0197	0.0428	CbGbCtD
Oxcarbazepine—CYP3A4—Erlotinib—pancreatic cancer	0.0167	0.0364	CbGbCtD
Oxcarbazepine—CYP3A4—Irinotecan—pancreatic cancer	0.0151	0.0329	CbGbCtD
Oxcarbazepine—CYP3A4—Docetaxel—pancreatic cancer	0.0111	0.0241	CbGbCtD
Oxcarbazepine—CYP3A4—Sunitinib—pancreatic cancer	0.011	0.024	CbGbCtD
Oxcarbazepine—CYP3A4—Doxorubicin—pancreatic cancer	0.00825	0.018	CbGbCtD
Oxcarbazepine—Nepafenac—PTGS2—pancreatic cancer	0.000284	0.267	CrCbGaD
Oxcarbazepine—Magnesium salicylate—PTGS2—pancreatic cancer	0.000278	0.261	CrCbGaD
Oxcarbazepine—Piroxicam—PTGS2—pancreatic cancer	0.000266	0.25	CrCbGaD
Oxcarbazepine—Salsalate—PTGS2—pancreatic cancer	0.000236	0.222	CrCbGaD
Oxcarbazepine—Myalgia—Docetaxel—pancreatic cancer	0.000113	0.000508	CcSEcCtD
Oxcarbazepine—Nausea—Sunitinib—pancreatic cancer	0.000113	0.000508	CcSEcCtD
Oxcarbazepine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000113	0.000508	CcSEcCtD
Oxcarbazepine—Renal failure—Epirubicin—pancreatic cancer	0.000112	0.000507	CcSEcCtD
Oxcarbazepine—Asthenia—Irinotecan—pancreatic cancer	0.000112	0.000506	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000112	0.000505	CcSEcCtD
Oxcarbazepine—Stomatitis—Epirubicin—pancreatic cancer	0.000111	0.000502	CcSEcCtD
Oxcarbazepine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000111	0.000501	CcSEcCtD
Oxcarbazepine—Neutropenia—Doxorubicin—pancreatic cancer	0.000111	0.0005	CcSEcCtD
Oxcarbazepine—Dysuria—Doxorubicin—pancreatic cancer	0.000111	0.0005	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00011	0.000498	CcSEcCtD
Oxcarbazepine—Dry mouth—Docetaxel—pancreatic cancer	0.00011	0.000497	CcSEcCtD
Oxcarbazepine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.00011	0.000497	CcSEcCtD
Oxcarbazepine—Pollakiuria—Doxorubicin—pancreatic cancer	0.00011	0.000494	CcSEcCtD
Oxcarbazepine—Asthenia—Gemcitabine—pancreatic cancer	0.000109	0.000493	CcSEcCtD
Oxcarbazepine—Haematuria—Epirubicin—pancreatic cancer	0.000109	0.000492	CcSEcCtD
Oxcarbazepine—Confusional state—Docetaxel—pancreatic cancer	0.000109	0.000492	CcSEcCtD
Oxcarbazepine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000108	0.000488	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000108	0.000488	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000108	0.000487	CcSEcCtD
Oxcarbazepine—Weight increased—Doxorubicin—pancreatic cancer	0.000108	0.000487	CcSEcCtD
Oxcarbazepine—Epistaxis—Epirubicin—pancreatic cancer	0.000108	0.000486	CcSEcCtD
Oxcarbazepine—Pruritus—Gemcitabine—pancreatic cancer	0.000108	0.000486	CcSEcCtD
Oxcarbazepine—Infection—Docetaxel—pancreatic cancer	0.000107	0.000484	CcSEcCtD
Oxcarbazepine—Weight decreased—Doxorubicin—pancreatic cancer	0.000107	0.000484	CcSEcCtD
Oxcarbazepine—Sinusitis—Epirubicin—pancreatic cancer	0.000107	0.000484	CcSEcCtD
Oxcarbazepine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000107	0.000483	CcSEcCtD
Oxcarbazepine—Diarrhoea—Irinotecan—pancreatic cancer	0.000107	0.000482	CcSEcCtD
Oxcarbazepine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000107	0.000481	CcSEcCtD
Oxcarbazepine—Pneumonia—Doxorubicin—pancreatic cancer	0.000106	0.00048	CcSEcCtD
Oxcarbazepine—Shock—Docetaxel—pancreatic cancer	0.000106	0.00048	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000106	0.000478	CcSEcCtD
Oxcarbazepine—Pruritus—Fluorouracil—pancreatic cancer	0.000106	0.000478	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000106	0.000477	CcSEcCtD
Oxcarbazepine—Infestation—Doxorubicin—pancreatic cancer	0.000106	0.000477	CcSEcCtD
Oxcarbazepine—Infestation NOS—Doxorubicin—pancreatic cancer	0.000106	0.000477	CcSEcCtD
Oxcarbazepine—Tachycardia—Docetaxel—pancreatic cancer	0.000105	0.000476	CcSEcCtD
Oxcarbazepine—Skin disorder—Docetaxel—pancreatic cancer	0.000105	0.000473	CcSEcCtD
Oxcarbazepine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000105	0.000473	CcSEcCtD
Oxcarbazepine—Bradycardia—Epirubicin—pancreatic cancer	0.000104	0.000471	CcSEcCtD
Oxcarbazepine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000104	0.00047	CcSEcCtD
Oxcarbazepine—Renal failure—Doxorubicin—pancreatic cancer	0.000104	0.000469	CcSEcCtD
Oxcarbazepine—Dizziness—Irinotecan—pancreatic cancer	0.000103	0.000466	CcSEcCtD
Oxcarbazepine—Stomatitis—Doxorubicin—pancreatic cancer	0.000103	0.000465	CcSEcCtD
Oxcarbazepine—Anorexia—Docetaxel—pancreatic cancer	0.000103	0.000465	CcSEcCtD
Oxcarbazepine—Rhinitis—Epirubicin—pancreatic cancer	0.000103	0.000464	CcSEcCtD
Oxcarbazepine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000103	0.000464	CcSEcCtD
Oxcarbazepine—Hepatitis—Epirubicin—pancreatic cancer	0.000103	0.000463	CcSEcCtD
Oxcarbazepine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000102	0.000462	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000102	0.00046	CcSEcCtD
Oxcarbazepine—Pharyngitis—Epirubicin—pancreatic cancer	0.000102	0.000459	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000101	0.000456	CcSEcCtD
Oxcarbazepine—Hypotension—Docetaxel—pancreatic cancer	0.000101	0.000455	CcSEcCtD
Oxcarbazepine—Haematuria—Doxorubicin—pancreatic cancer	0.000101	0.000455	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.0001	0.000451	CcSEcCtD
Oxcarbazepine—Epistaxis—Doxorubicin—pancreatic cancer	9.97e-05	0.00045	CcSEcCtD
Oxcarbazepine—Vomiting—Irinotecan—pancreatic cancer	9.94e-05	0.000448	CcSEcCtD
Oxcarbazepine—Sinusitis—Doxorubicin—pancreatic cancer	9.92e-05	0.000448	CcSEcCtD
Oxcarbazepine—Dizziness—Fluorouracil—pancreatic cancer	9.9e-05	0.000447	CcSEcCtD
Oxcarbazepine—Visual impairment—Epirubicin—pancreatic cancer	9.89e-05	0.000446	CcSEcCtD
Oxcarbazepine—Agranulocytosis—Doxorubicin—pancreatic cancer	9.87e-05	0.000445	CcSEcCtD
Oxcarbazepine—Rash—Irinotecan—pancreatic cancer	9.86e-05	0.000445	CcSEcCtD
Oxcarbazepine—Dermatitis—Irinotecan—pancreatic cancer	9.85e-05	0.000444	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	9.84e-05	0.000444	CcSEcCtD
Oxcarbazepine—Headache—Irinotecan—pancreatic cancer	9.79e-05	0.000442	CcSEcCtD
Oxcarbazepine—Insomnia—Docetaxel—pancreatic cancer	9.77e-05	0.000441	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Epirubicin—pancreatic cancer	9.7e-05	0.000438	CcSEcCtD
Oxcarbazepine—Vomiting—Gemcitabine—pancreatic cancer	9.68e-05	0.000437	CcSEcCtD
Oxcarbazepine—Bradycardia—Doxorubicin—pancreatic cancer	9.66e-05	0.000436	CcSEcCtD
Oxcarbazepine—Dyspnoea—Docetaxel—pancreatic cancer	9.63e-05	0.000435	CcSEcCtD
Oxcarbazepine—Somnolence—Docetaxel—pancreatic cancer	9.61e-05	0.000433	CcSEcCtD
Oxcarbazepine—Rash—Gemcitabine—pancreatic cancer	9.6e-05	0.000433	CcSEcCtD
Oxcarbazepine—Dermatitis—Gemcitabine—pancreatic cancer	9.59e-05	0.000433	CcSEcCtD
Oxcarbazepine—Eye disorder—Epirubicin—pancreatic cancer	9.59e-05	0.000432	CcSEcCtD
Oxcarbazepine—Tinnitus—Epirubicin—pancreatic cancer	9.56e-05	0.000431	CcSEcCtD
Oxcarbazepine—Headache—Gemcitabine—pancreatic cancer	9.54e-05	0.00043	CcSEcCtD
Oxcarbazepine—Flushing—Epirubicin—pancreatic cancer	9.52e-05	0.000429	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Epirubicin—pancreatic cancer	9.52e-05	0.000429	CcSEcCtD
Oxcarbazepine—Vomiting—Fluorouracil—pancreatic cancer	9.52e-05	0.000429	CcSEcCtD
Oxcarbazepine—Rhinitis—Doxorubicin—pancreatic cancer	9.52e-05	0.000429	CcSEcCtD
Oxcarbazepine—Dyspepsia—Docetaxel—pancreatic cancer	9.51e-05	0.000429	CcSEcCtD
Oxcarbazepine—Hepatitis—Doxorubicin—pancreatic cancer	9.49e-05	0.000428	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Doxorubicin—pancreatic cancer	9.44e-05	0.000426	CcSEcCtD
Oxcarbazepine—Rash—Fluorouracil—pancreatic cancer	9.44e-05	0.000426	CcSEcCtD
Oxcarbazepine—Dermatitis—Fluorouracil—pancreatic cancer	9.43e-05	0.000425	CcSEcCtD
Oxcarbazepine—Pharyngitis—Doxorubicin—pancreatic cancer	9.42e-05	0.000425	CcSEcCtD
Oxcarbazepine—Decreased appetite—Docetaxel—pancreatic cancer	9.39e-05	0.000424	CcSEcCtD
Oxcarbazepine—Headache—Fluorouracil—pancreatic cancer	9.38e-05	0.000423	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Doxorubicin—pancreatic cancer	9.35e-05	0.000422	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	9.33e-05	0.000421	CcSEcCtD
Oxcarbazepine—Fatigue—Docetaxel—pancreatic cancer	9.32e-05	0.00042	CcSEcCtD
Oxcarbazepine—Angiopathy—Epirubicin—pancreatic cancer	9.31e-05	0.00042	CcSEcCtD
Oxcarbazepine—Nausea—Irinotecan—pancreatic cancer	9.28e-05	0.000419	CcSEcCtD
Oxcarbazepine—Immune system disorder—Epirubicin—pancreatic cancer	9.27e-05	0.000418	CcSEcCtD
Oxcarbazepine—Constipation—Docetaxel—pancreatic cancer	9.24e-05	0.000417	CcSEcCtD
Oxcarbazepine—Pain—Docetaxel—pancreatic cancer	9.24e-05	0.000417	CcSEcCtD
Oxcarbazepine—Chills—Epirubicin—pancreatic cancer	9.2e-05	0.000415	CcSEcCtD
Oxcarbazepine—Arrhythmia—Epirubicin—pancreatic cancer	9.16e-05	0.000413	CcSEcCtD
Oxcarbazepine—Visual impairment—Doxorubicin—pancreatic cancer	9.15e-05	0.000413	CcSEcCtD
Oxcarbazepine—Alopecia—Epirubicin—pancreatic cancer	9.06e-05	0.000409	CcSEcCtD
Oxcarbazepine—Nausea—Gemcitabine—pancreatic cancer	9.04e-05	0.000408	CcSEcCtD
Oxcarbazepine—Mental disorder—Epirubicin—pancreatic cancer	8.99e-05	0.000405	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Doxorubicin—pancreatic cancer	8.97e-05	0.000405	CcSEcCtD
Oxcarbazepine—Malnutrition—Epirubicin—pancreatic cancer	8.93e-05	0.000403	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Docetaxel—pancreatic cancer	8.9e-05	0.000402	CcSEcCtD
Oxcarbazepine—Nausea—Fluorouracil—pancreatic cancer	8.89e-05	0.000401	CcSEcCtD
Oxcarbazepine—Eye disorder—Doxorubicin—pancreatic cancer	8.87e-05	0.0004	CcSEcCtD
Oxcarbazepine—Tinnitus—Doxorubicin—pancreatic cancer	8.85e-05	0.000399	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Docetaxel—pancreatic cancer	8.84e-05	0.000399	CcSEcCtD
Oxcarbazepine—Flushing—Doxorubicin—pancreatic cancer	8.81e-05	0.000397	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Doxorubicin—pancreatic cancer	8.81e-05	0.000397	CcSEcCtD
Oxcarbazepine—Flatulence—Epirubicin—pancreatic cancer	8.8e-05	0.000397	CcSEcCtD
Oxcarbazepine—Tension—Epirubicin—pancreatic cancer	8.76e-05	0.000395	CcSEcCtD
Oxcarbazepine—Dysgeusia—Epirubicin—pancreatic cancer	8.74e-05	0.000395	CcSEcCtD
Oxcarbazepine—Nervousness—Epirubicin—pancreatic cancer	8.67e-05	0.000391	CcSEcCtD
Oxcarbazepine—Back pain—Epirubicin—pancreatic cancer	8.64e-05	0.00039	CcSEcCtD
Oxcarbazepine—Angiopathy—Doxorubicin—pancreatic cancer	8.61e-05	0.000388	CcSEcCtD
Oxcarbazepine—Immune system disorder—Doxorubicin—pancreatic cancer	8.57e-05	0.000387	CcSEcCtD
Oxcarbazepine—Abdominal pain—Docetaxel—pancreatic cancer	8.54e-05	0.000385	CcSEcCtD
Oxcarbazepine—Body temperature increased—Docetaxel—pancreatic cancer	8.54e-05	0.000385	CcSEcCtD
Oxcarbazepine—Chills—Doxorubicin—pancreatic cancer	8.52e-05	0.000384	CcSEcCtD
Oxcarbazepine—Arrhythmia—Doxorubicin—pancreatic cancer	8.48e-05	0.000383	CcSEcCtD
Oxcarbazepine—Vision blurred—Epirubicin—pancreatic cancer	8.42e-05	0.00038	CcSEcCtD
Oxcarbazepine—Alopecia—Doxorubicin—pancreatic cancer	8.39e-05	0.000378	CcSEcCtD
Oxcarbazepine—Mental disorder—Doxorubicin—pancreatic cancer	8.32e-05	0.000375	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Epirubicin—pancreatic cancer	8.29e-05	0.000374	CcSEcCtD
Oxcarbazepine—Malnutrition—Doxorubicin—pancreatic cancer	8.26e-05	0.000373	CcSEcCtD
Oxcarbazepine—Agitation—Epirubicin—pancreatic cancer	8.21e-05	0.00037	CcSEcCtD
Oxcarbazepine—Flatulence—Doxorubicin—pancreatic cancer	8.14e-05	0.000367	CcSEcCtD
Oxcarbazepine—Tension—Doxorubicin—pancreatic cancer	8.11e-05	0.000366	CcSEcCtD
Oxcarbazepine—Dysgeusia—Doxorubicin—pancreatic cancer	8.09e-05	0.000365	CcSEcCtD
Oxcarbazepine—Malaise—Epirubicin—pancreatic cancer	8.05e-05	0.000363	CcSEcCtD
Oxcarbazepine—Nervousness—Doxorubicin—pancreatic cancer	8.02e-05	0.000362	CcSEcCtD
Oxcarbazepine—Vertigo—Epirubicin—pancreatic cancer	8.02e-05	0.000362	CcSEcCtD
Oxcarbazepine—Syncope—Epirubicin—pancreatic cancer	8.01e-05	0.000361	CcSEcCtD
Oxcarbazepine—Leukopenia—Epirubicin—pancreatic cancer	7.99e-05	0.000361	CcSEcCtD
Oxcarbazepine—Back pain—Doxorubicin—pancreatic cancer	7.99e-05	0.000361	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Docetaxel—pancreatic cancer	7.96e-05	0.000359	CcSEcCtD
Oxcarbazepine—Palpitations—Epirubicin—pancreatic cancer	7.89e-05	0.000356	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Epirubicin—pancreatic cancer	7.85e-05	0.000354	CcSEcCtD
Oxcarbazepine—Cough—Epirubicin—pancreatic cancer	7.79e-05	0.000352	CcSEcCtD
Oxcarbazepine—Vision blurred—Doxorubicin—pancreatic cancer	7.79e-05	0.000351	CcSEcCtD
Oxcarbazepine—Asthenia—Docetaxel—pancreatic cancer	7.75e-05	0.00035	CcSEcCtD
Oxcarbazepine—Convulsion—Epirubicin—pancreatic cancer	7.74e-05	0.000349	CcSEcCtD
Oxcarbazepine—Hypertension—Epirubicin—pancreatic cancer	7.71e-05	0.000348	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Doxorubicin—pancreatic cancer	7.67e-05	0.000346	CcSEcCtD
Oxcarbazepine—Pruritus—Docetaxel—pancreatic cancer	7.64e-05	0.000345	CcSEcCtD
Oxcarbazepine—Myalgia—Epirubicin—pancreatic cancer	7.6e-05	0.000343	CcSEcCtD
Oxcarbazepine—Chest pain—Epirubicin—pancreatic cancer	7.6e-05	0.000343	CcSEcCtD
Oxcarbazepine—Arthralgia—Epirubicin—pancreatic cancer	7.6e-05	0.000343	CcSEcCtD
Oxcarbazepine—Agitation—Doxorubicin—pancreatic cancer	7.59e-05	0.000343	CcSEcCtD
Oxcarbazepine—Anxiety—Epirubicin—pancreatic cancer	7.58e-05	0.000342	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	7.55e-05	0.000341	CcSEcCtD
Oxcarbazepine—Discomfort—Epirubicin—pancreatic cancer	7.51e-05	0.000339	CcSEcCtD
Oxcarbazepine—Malaise—Doxorubicin—pancreatic cancer	7.45e-05	0.000336	CcSEcCtD
Oxcarbazepine—Dry mouth—Epirubicin—pancreatic cancer	7.44e-05	0.000335	CcSEcCtD
Oxcarbazepine—Vertigo—Doxorubicin—pancreatic cancer	7.42e-05	0.000335	CcSEcCtD
Oxcarbazepine—Syncope—Doxorubicin—pancreatic cancer	7.41e-05	0.000334	CcSEcCtD
Oxcarbazepine—Leukopenia—Doxorubicin—pancreatic cancer	7.4e-05	0.000334	CcSEcCtD
Oxcarbazepine—Diarrhoea—Docetaxel—pancreatic cancer	7.39e-05	0.000334	CcSEcCtD
Oxcarbazepine—Confusional state—Epirubicin—pancreatic cancer	7.35e-05	0.000332	CcSEcCtD
Oxcarbazepine—Palpitations—Doxorubicin—pancreatic cancer	7.3e-05	0.000329	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Epirubicin—pancreatic cancer	7.29e-05	0.000329	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Doxorubicin—pancreatic cancer	7.26e-05	0.000328	CcSEcCtD
Oxcarbazepine—Infection—Epirubicin—pancreatic cancer	7.24e-05	0.000327	CcSEcCtD
Oxcarbazepine—Cough—Doxorubicin—pancreatic cancer	7.21e-05	0.000325	CcSEcCtD
Oxcarbazepine—Shock—Epirubicin—pancreatic cancer	7.17e-05	0.000323	CcSEcCtD
Oxcarbazepine—Convulsion—Doxorubicin—pancreatic cancer	7.16e-05	0.000323	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Epirubicin—pancreatic cancer	7.15e-05	0.000322	CcSEcCtD
Oxcarbazepine—Dizziness—Docetaxel—pancreatic cancer	7.15e-05	0.000322	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Epirubicin—pancreatic cancer	7.14e-05	0.000322	CcSEcCtD
Oxcarbazepine—Hypertension—Doxorubicin—pancreatic cancer	7.13e-05	0.000322	CcSEcCtD
Oxcarbazepine—Tachycardia—Epirubicin—pancreatic cancer	7.11e-05	0.000321	CcSEcCtD
Oxcarbazepine—Skin disorder—Epirubicin—pancreatic cancer	7.08e-05	0.000319	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Epirubicin—pancreatic cancer	7.05e-05	0.000318	CcSEcCtD
Oxcarbazepine—Chest pain—Doxorubicin—pancreatic cancer	7.03e-05	0.000317	CcSEcCtD
Oxcarbazepine—Arthralgia—Doxorubicin—pancreatic cancer	7.03e-05	0.000317	CcSEcCtD
Oxcarbazepine—Myalgia—Doxorubicin—pancreatic cancer	7.03e-05	0.000317	CcSEcCtD
Oxcarbazepine—Anxiety—Doxorubicin—pancreatic cancer	7.01e-05	0.000316	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	6.99e-05	0.000315	CcSEcCtD
Oxcarbazepine—Discomfort—Doxorubicin—pancreatic cancer	6.95e-05	0.000314	CcSEcCtD
Oxcarbazepine—Anorexia—Epirubicin—pancreatic cancer	6.95e-05	0.000313	CcSEcCtD
Oxcarbazepine—Dry mouth—Doxorubicin—pancreatic cancer	6.88e-05	0.00031	CcSEcCtD
Oxcarbazepine—Vomiting—Docetaxel—pancreatic cancer	6.87e-05	0.00031	CcSEcCtD
Oxcarbazepine—Rash—Docetaxel—pancreatic cancer	6.81e-05	0.000307	CcSEcCtD
Oxcarbazepine—Hypotension—Epirubicin—pancreatic cancer	6.81e-05	0.000307	CcSEcCtD
Oxcarbazepine—Dermatitis—Docetaxel—pancreatic cancer	6.81e-05	0.000307	CcSEcCtD
Oxcarbazepine—Confusional state—Doxorubicin—pancreatic cancer	6.8e-05	0.000307	CcSEcCtD
Oxcarbazepine—Headache—Docetaxel—pancreatic cancer	6.77e-05	0.000305	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Doxorubicin—pancreatic cancer	6.74e-05	0.000304	CcSEcCtD
Oxcarbazepine—Infection—Doxorubicin—pancreatic cancer	6.7e-05	0.000302	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	6.64e-05	0.0003	CcSEcCtD
Oxcarbazepine—Shock—Doxorubicin—pancreatic cancer	6.63e-05	0.000299	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Doxorubicin—pancreatic cancer	6.61e-05	0.000298	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Doxorubicin—pancreatic cancer	6.6e-05	0.000298	CcSEcCtD
Oxcarbazepine—Insomnia—Epirubicin—pancreatic cancer	6.59e-05	0.000297	CcSEcCtD
Oxcarbazepine—Tachycardia—Doxorubicin—pancreatic cancer	6.58e-05	0.000297	CcSEcCtD
Oxcarbazepine—Skin disorder—Doxorubicin—pancreatic cancer	6.55e-05	0.000295	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Doxorubicin—pancreatic cancer	6.52e-05	0.000294	CcSEcCtD
Oxcarbazepine—Dyspnoea—Epirubicin—pancreatic cancer	6.5e-05	0.000293	CcSEcCtD
Oxcarbazepine—Somnolence—Epirubicin—pancreatic cancer	6.48e-05	0.000292	CcSEcCtD
Oxcarbazepine—Anorexia—Doxorubicin—pancreatic cancer	6.43e-05	0.00029	CcSEcCtD
Oxcarbazepine—Nausea—Docetaxel—pancreatic cancer	6.42e-05	0.00029	CcSEcCtD
Oxcarbazepine—Dyspepsia—Epirubicin—pancreatic cancer	6.42e-05	0.000289	CcSEcCtD
Oxcarbazepine—Decreased appetite—Epirubicin—pancreatic cancer	6.34e-05	0.000286	CcSEcCtD
Oxcarbazepine—Hypotension—Doxorubicin—pancreatic cancer	6.3e-05	0.000284	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.29e-05	0.000284	CcSEcCtD
Oxcarbazepine—Fatigue—Epirubicin—pancreatic cancer	6.28e-05	0.000283	CcSEcCtD
Oxcarbazepine—Constipation—Epirubicin—pancreatic cancer	6.23e-05	0.000281	CcSEcCtD
Oxcarbazepine—Pain—Epirubicin—pancreatic cancer	6.23e-05	0.000281	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	6.14e-05	0.000277	CcSEcCtD
Oxcarbazepine—Insomnia—Doxorubicin—pancreatic cancer	6.1e-05	0.000275	CcSEcCtD
Oxcarbazepine—Dyspnoea—Doxorubicin—pancreatic cancer	6.01e-05	0.000271	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Epirubicin—pancreatic cancer	6.01e-05	0.000271	CcSEcCtD
Oxcarbazepine—Somnolence—Doxorubicin—pancreatic cancer	5.99e-05	0.00027	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Epirubicin—pancreatic cancer	5.96e-05	0.000269	CcSEcCtD
Oxcarbazepine—Dyspepsia—Doxorubicin—pancreatic cancer	5.94e-05	0.000268	CcSEcCtD
Oxcarbazepine—Decreased appetite—Doxorubicin—pancreatic cancer	5.86e-05	0.000264	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	5.82e-05	0.000263	CcSEcCtD
Oxcarbazepine—Fatigue—Doxorubicin—pancreatic cancer	5.81e-05	0.000262	CcSEcCtD
Oxcarbazepine—Urticaria—Epirubicin—pancreatic cancer	5.79e-05	0.000261	CcSEcCtD
Oxcarbazepine—Constipation—Doxorubicin—pancreatic cancer	5.77e-05	0.00026	CcSEcCtD
Oxcarbazepine—Pain—Doxorubicin—pancreatic cancer	5.77e-05	0.00026	CcSEcCtD
Oxcarbazepine—Body temperature increased—Epirubicin—pancreatic cancer	5.76e-05	0.00026	CcSEcCtD
Oxcarbazepine—Abdominal pain—Epirubicin—pancreatic cancer	5.76e-05	0.00026	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Doxorubicin—pancreatic cancer	5.56e-05	0.000251	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.51e-05	0.000249	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Epirubicin—pancreatic cancer	5.37e-05	0.000242	CcSEcCtD
Oxcarbazepine—Urticaria—Doxorubicin—pancreatic cancer	5.36e-05	0.000242	CcSEcCtD
Oxcarbazepine—Body temperature increased—Doxorubicin—pancreatic cancer	5.33e-05	0.00024	CcSEcCtD
Oxcarbazepine—Abdominal pain—Doxorubicin—pancreatic cancer	5.33e-05	0.00024	CcSEcCtD
Oxcarbazepine—Asthenia—Epirubicin—pancreatic cancer	5.23e-05	0.000236	CcSEcCtD
Oxcarbazepine—Pruritus—Epirubicin—pancreatic cancer	5.16e-05	0.000233	CcSEcCtD
Oxcarbazepine—Diarrhoea—Epirubicin—pancreatic cancer	4.99e-05	0.000225	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Doxorubicin—pancreatic cancer	4.97e-05	0.000224	CcSEcCtD
Oxcarbazepine—Asthenia—Doxorubicin—pancreatic cancer	4.84e-05	0.000218	CcSEcCtD
Oxcarbazepine—Dizziness—Epirubicin—pancreatic cancer	4.82e-05	0.000217	CcSEcCtD
Oxcarbazepine—Pruritus—Doxorubicin—pancreatic cancer	4.77e-05	0.000215	CcSEcCtD
Oxcarbazepine—Vomiting—Epirubicin—pancreatic cancer	4.63e-05	0.000209	CcSEcCtD
Oxcarbazepine—Diarrhoea—Doxorubicin—pancreatic cancer	4.61e-05	0.000208	CcSEcCtD
Oxcarbazepine—Rash—Epirubicin—pancreatic cancer	4.6e-05	0.000207	CcSEcCtD
Oxcarbazepine—Dermatitis—Epirubicin—pancreatic cancer	4.59e-05	0.000207	CcSEcCtD
Oxcarbazepine—Headache—Epirubicin—pancreatic cancer	4.57e-05	0.000206	CcSEcCtD
Oxcarbazepine—Dizziness—Doxorubicin—pancreatic cancer	4.46e-05	0.000201	CcSEcCtD
Oxcarbazepine—Nausea—Epirubicin—pancreatic cancer	4.33e-05	0.000195	CcSEcCtD
Oxcarbazepine—Vomiting—Doxorubicin—pancreatic cancer	4.29e-05	0.000193	CcSEcCtD
Oxcarbazepine—Rash—Doxorubicin—pancreatic cancer	4.25e-05	0.000192	CcSEcCtD
Oxcarbazepine—Dermatitis—Doxorubicin—pancreatic cancer	4.25e-05	0.000192	CcSEcCtD
Oxcarbazepine—Headache—Doxorubicin—pancreatic cancer	4.22e-05	0.000191	CcSEcCtD
Oxcarbazepine—Nausea—Doxorubicin—pancreatic cancer	4.01e-05	0.000181	CcSEcCtD
